Tendo Sato
Papers
1
Total Citations
13
H-Index
1
About
Dr. Tendo Sato is a pioneering urological researcher whose work centers on the development of novel, non-invasive biomarkers for surgical assessment. His primary research area involves the clinical application of cell-free DNA (cfDNA) to evaluate tissue damage and surgical stress in urological procedures. Dr. Sato’s most impactful contribution is his landmark 2021 study, "Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries," which has garnered 13 citations. This work demonstrated that perioperative total cfDNA levels rise significantly in response to surgical trauma, offering a specific and quantifiable biomarker where none previously existed. By providing a molecular tool to objectively measure surgical damage, Dr. Sato’s research addresses a critical gap in postoperative care, potentially enabling more precise recovery monitoring and complication prediction. His findings have opened new avenues for personalized surgical management, positioning him as a leading voice in translational urology and liquid biopsy research.
Research Focus
Key Achievements
Top Papers
- 1